World Health Organization, Regional Office for South-East Asia. Capacity building for birth defects surveillance in South-East Asia: report of the regional workshop on birth defects surveillance, Colombo, Sri Lanka; 2012. https://apps.who.int/iris/handle/10665/204844. Accessed 28 July, 2020.
Christianson A, Modell B. Medical genetics in developing countries. Annu Rev Genomics Hum Genet. 2004;5:219–65.
Verma IC, Puri RD. Global burden of genetic disease and the role of genetic screening. Semin Fetal Neonatal Med. 2015;20:354–63.
World Health Organization, Regional Office for South-East Asia. Prevention and control of birth defects in South-East Asia region: strategic framework (2013–2017); 2013. https://apps.who.int/iris/handle/10665/205644. Accessed 28 July, 2020.
National Health Mission: Child Health. https://nhm.gov.in/index1.php?lang=1&level=2&sublinkid=819&lid=219. Accessed 28 July, 2020.
Swain S, Agrawal A, Bhatia BD. Congenital malformations at birth. Indian Pediatr. 1994;31:1187–91.
Verma IC, Bijarnia S. The burden of genetic disorders in India and a framework for community control. Community Genet. 2002;5:192–6.
Baird PA, Anderson TW, Newcombe HB, Lowry RB. Genetic disorders in children and young adults: a population study. Am J Hum Genet. 1988;42:677–93.
Czeizel A, Sankaranarayanan K. The load of genetic and partially genetic disorders in man. I. Congenital anomalies: estimates of detriment in terms of years of life lost and years of impaired life. Mutat Res. 1984;128:73–103.
Angastiniotis M, Kyriakidou S, Hadjiminas M. How thalassemia was controlled in Cyprus. World Health Forum. 1986;7:291–7.
Ginsberg G, Tulchinsky T, Filon D, Goldfarb A, Abramov L, Rachmilevitz EA. Cost-benefit analysis of a national thalassaemia prevention programme in Israel. J Med Screen. 1998;5:120–6.
Sukumaran A. Am I going to live? Genetic diseases leave 70 million Indians at God’s mercy. In: Outlook magazine; 2019. https://www.outlookindia.com/magazine/story/india-news-am-i-going-to-live-genetic-diseases-leave-70-million-indians-at-gods-mercy/301809. Accessed 26 July, 2020.
Adarsh A, Bhat D, Nataraj R. India rare disease initiatives–a review. Int J Innov Med Health Sci. 2020;12:82–8.
Andrade E, Díaz J. Cost-effectiveness of the CFTR gene-sequencing test for asymptomatic carriers in the Colombian population. CF Biomedica. 2020;40:183–95.
Warren E, Anderson R, Proos AL, Burnett LB, Barlow-Stewart K, Hall J. Cost-effectiveness of a school-based Tay-Sachs and cystic fibrosis genetic carrier screening program. Genet Med. 2005;7:484–94.
Beauchamp KA, Johansen Taber KA, Muzzey D. Clinical impact and cost-effectiveness of a 176-condition expanded carrier screen. Genet Med. 2019;21:1948–57.
Zhang L, Bao Y, Riaz M, Tiller J, Liew D, Zhuang X, et al. Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis. Genet Med. 2019;21:1958–68.
Bijarnia-Mahay S, Arora V, Saxena R, Verma IC. The changing scenario in prenatal diagnosis of genetic disorders: genetics to genomics. Curr Med Res Pract. 2018;1:8203–8.
Rose NC, Wick M. Carrier screening for single gene disorders. Semin Fetal Neonatal Med. 2018;23:78–84.
Madan N, Sharma S, Sood SK, Colah R, Bhatia LH. Frequency of β-thalassemia trait and other hemoglobinopathies in northern and western India. Indian J Hum Genet. 2010;16:16–25.
Kapoor V, Shastri SS, Kabra M, Kabra SK, Ramachandran V, Arora S, et al. Carrier frequency of F508del mutation of cystic fibrosis in Indian population. J Cyst Fibros. 2006;5:43–6.
RamShankar M, Girirajan S, Dagan O, Ravi Shankar HM, Jalvi R, Rangasayee R, et al. Contribution of connexin26 (GJB2) mutations and founder effect to non-syndromic hearing loss in India. J Med Genet. 2003;40:e68.
Verma IC, Kohli S, Shenbagam S, Bijarnia-Mahay S, Puri RD, Saxena R. Carrier screening of spinal muscular atrophy in north Indian population and its public health implications. Clin Genet. 2020;98:198–9.
Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc. 1927;22:209–12.
Andermann A, Blancquaert I, Beauchamp S, Déry V. Revisiting Wilson and Jungner in the Genomic Age: A Review of Screening Criteria over the Past 40 Years. http://www.who.int/bulletin/volumes/86/4/07-050112/en/. Accessed 29 July, 2020.
Ankala A, Tamhankar PM, Valencia CA, Rayam KK, Kumar MM, Hegde MR. Clinical applications and implications of common and founder mutations in Indian subpopulations. Hum Mutat. 2015;36:1–10.
Garg S, Chadha S, Malhotra S, Agarwal AK. Deafness: burden, prevention and control in India. Natl Med J India. 2009;22:79–81.
Mandal A, Kabra SK, Lodha R. Cystic fibrosis in India: past, present and future. J Pulm Med Respir Res. 2015;1:002.
Lazarin GA, Haque IS, Nazareth S, Lori K, Patterson AS, Jacobson JL, et al. An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals. Genet Med. 2013;15:178–86.
Grody WW, Thompson BH, Gregg AR, Bean LH, Monaghan KG, Schneider A, et al. ACMG position statement on prenatal/preconception expanded carrier screening. Genet Med. 2013;15(6):482–3.
Li H, Durbin R. Fast and accurate long-read alignment with burrows-wheeler transform. Bioinformatics. 2010;26:589–95.
Haeussler M, Zweig AS, Tyner C, Speir ML, Rosenbloom KR, Raney BJ, et al. The UCSC genome browser database: 2019 update. Nucleic Acids Res. 2019;47(D1):D853–8.
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–303.
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. 1000 genome project data processing subgroup. The sequence alignment/map format and SAMtools. Bioinformatics. 2009;25:2078–9 Accessed 5 May, 2018.
Zerbino DR, Achuthan P, Akanni W, Amode MR, Barrell D, Bhai J, et al. Ensembl 2018. Nucleic Acids Res. 2018;46(D1):D754–61 https://asia.ensembl.org/index.html. Accessed 5 May, 2018.
Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062–7 https://www.ncbi.nlm.nih.gov/clinvar/. Accessed 1 August, 2020.
Hamosh A, Scott AF, Amberger JS, Bocchini CA, McKusick VA. Online Mendelian inheritance in man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 2005;33:D514–7 https://www.omim.org/. Accessed 1 August, 2020.
Welter D, MacArthur J, Morales J, Burdett T, Hall P, Junkins H, et al. The NHGRI GWAS catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 2014;42:D1001–6 https://www.ebi.ac.uk/gwas/. Accessed 10 May, 2018.
Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, et al. Human gene mutation database (HGMD): 2003 update. Hum Mutat. 2003;21(6):577–81 www.hgmd.cf.ac.uk/. Accessed 10 May, 2018.
Mottaz A, David FP, Veuthey AL, Yip YL. Easy retrieval of single amino-acid polymorphisms and phenotype information using SwissVar. Bioinformatics. 2010;26(6):851–2 https://swissvar.expasy.org/. Accessed 10 May, 2018.
1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68–74 phase3browser.1000genomes.org/. Accessed 10 May, 2018.
Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Exome aggregation consortium. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285–91 gnomad.broadinstitute.org/. Accessed 10 May, 2018.
Sherry ST, Ward M, Sirotkin K. dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Res. 1999;9:677–9 https://www.ncbi.nlm.nih.gov/projects/SNP/. Accessed 13 May, 2018.
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–9 http://genetics.bwh.harvard.edu/pph2/. Accessed 13 May, 2018.
Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073–81 http://sift.jcvi.org/www/SIFT_enst_submit.html. Accessed 13 May, 2018.
Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods. 2014;11:361–2 http://www.mutationtaster.org/. Accessed 15 May, 2018.
Reva B, Antipin Y, Sander C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 2011;39:e118 http://www.mutationassessor.org/. Accessed 15 May, 2018.
Chun S, Fay JC. Identification of deleterious mutations within three human genomes. Genome Res. 2009;19:1553–6.
Reese MG, Eeckman FH, Kulp D, Haussler D. Improved splice site detection in genie. J Comput Biol. 1997;4:311–23 http://www.fruitfly.org/seq_tools/splice.html. Accessed 20 May, 2018.
Desmet FO, Hamroun D, Lalande M, Collod-Béroud G, Claustres M, Béroud C. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67 http://www.umd.be/HSF3. Accessed 20 May, 2018.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
Colah R, Italia K, Gorakshakar A. Burden of thalassemia in India: the road map for control. Pediatr Hemat Oncol J. 2017;2(4):79–84.
Archibald AD, Smith MJ, Burgess T, Scarff KL, Elliott J, Hunt CE, et al. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests. Genet Med. 2018;20:513–23.
Woodcock IR, Fraser L, Norman P, Pysden K, Manning S, Childs AM. The prevalence of neuromuscular disease in the paediatric population in Yorkshire, UK; variation by ethnicity and deprivation status. Dev Med Child Neurol. 2016;58:877–83.
Sachdeva K, Saxena R, Majumdar A, Chadha S, Verma IC. Mutation studies in the CFTR gene in Asian Indian subjects with congenital bilateral absence of vas deferens: report of two novel mutations and four novel variants. Genetic Test Mol Biomark. 2011;15:307–12.
Shastri SS, Kabra M, Kabra SK, Pandey RM, Menon PS. Characterisation of mutations and genotype-phenotype correlation in cystic fibrosis: experience from India. J Cyst Fibros. 2008;7:110–5.
Sharma N, Singh M, Kaur G, Thapa BR, Prasad R. Identification and characterization of CFTR gene mutations in Indian CF patients. Ann Hum Genet. 2009;73:26–33.
Watson MS, Cutting GR, Desnick RJ, Driscoll DA, Klinger K, Mennuti M, et al. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med. 2004;6:387–91.
Sachdeva K, Saxena R, Puri R, Bijarnia S, Kohli S, Verma IC. Mutation analysis of the CFTR gene in 225 children: identification of five novel severe and seven reported severe mutations. Genet Test Mol Biomarkers. 2012;16:798–801.
Lim RM, Silver AJ, Silver MJ, Borroto C, Spurrier B, Petrossian TC, et al. Targeted mutation screening panels expose systematic population bias in detection of cystic fibrosis risk. Genet Med. 2016;18:174–9.
Bowler IM, Estlin EJ, Littlewood JM. Cystic fibrosis in Asians. Arch Dis Child. 1993;68:120–2.
Powers CA, Potter EM, Wessel HU, Lloyd-Still JD. Cystic fibrosis in Asian Indians. Arch Pediatr Adolesc Med. 1996;150:554–5.
Kabra M, Kabra SK, Ghosh M, Khanna A, Arora S, Menon PS, et al. Is the spectrum of mutations in Indian patients with cystic fibrosis different? Am J Med Genet. 2000;93:161–3.
Mei-Zahav M, Durie P, Zielenski J, Solomon M, Tullis E, TSui LC, et al. The prevalence and clinical characteristics of cystic fibrosis in south Asian Canadian immigrants. Arch Dis Child. 2005;90:675–9.
Green GE, Scott DA, McDonald JM, Woodworth GG, Sheffield VC, Smith RJ. Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA. 1999;281:2211–6.
Taniguchi M, Matsuo H, Shimizu S, Nakayama A, Suzuki K, Hamajima N, et al. Carrier frequency of the GJB2 mutations that cause hereditary hearing loss in the Japanese population. J Hum Genet. 2015;60:613–7.
Han SH, Park HJ, Kang EJ, Ryu JS, Lee A, Yang YH, et al. Carrier frequency of GJB2 (connexin-26) mutations causing inherited deafness in the Korean population. J Hum Genet. 2008;53:1022–8.
Sloan-Heggen CM, Bierer AO, Shearer AE, Kolbe DL, Nishimura CJ, Frees KL, et al. Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing loss. Hum Genet. 2016;135:441–50.
Van Hauwe P, Everett LA, Coucke P, Scott DA, Kraft ML, Ris-Stalpers C, et al. Two frequent missense mutations in Pendred syndrome. Hum Mol Genet. 1998;7:1099–104.
Madden C, Halsted M, Meinzen-Derr J, Bardo D, Boston M, Arjmand E, et al. The influence of mutations in the SLC26A4 gene on the temporal bone in a population with enlarged vestibular aqueduct. Arch Otolaryngol Head Neck Surg. 2007;133:162–8.
Kühnen P, Turan S, Fröhler S, Güran T, Abali S, Biebermann H, et al. Identification of PENDRIN (SLC26A4) mutations in patients with congenital hypothyroidism and “apparent” thyroid dysgenesis. J Clin Endocrinol Metab. 2014;99:E169–76.
Dossena S, Nofziger C, Brownstein Z, Kanaan M, Avraham KB, Paulmichl M. Functional characterization of pendrin mutations found in the Israeli and Palestinian populations. Cell Physiol Biochem. 2011;28:477–84.
Pera A, Villamar M, Viñuela A, Gandía M, Medà C, Moreno F, et al. A mutational analysis of the SLC26A4 gene in Spanish hearing-impaired families provides new insights into the genetic causes of Pendred syndrome and DFNB4 hearing loss. Eur J Hum Genet. 2008;16:888–96.
Nahar R, Puri RD, Saxena R, Verma IC. Do parental perceptions and motivations towards genetic testing and prenatal diagnosis for deafness vary in different cultures? Am J Med Genet A. 2013;161A:76–81.
Puri RD, Kapoor S, Kishnani PS, Dalal A, Gupta N, Muranjan M, et al. Diagnosis and Management of Gaucher Disease in India - consensus guidelines of the Gaucher disease task force of the Society for Indian Academy of medical genetics and the Indian academy of pediatrics. Indian Pediatr. 2018;55:143–53.
Ankleshwaria C, Mistri M, Bavdekar A, Muranjan M, Dave U, Tamhankar P, et al. Novel mutations in the glucocerebrosidase gene of Indian patients with Gaucher disease. J Hum Genet. 2014;59:223–8.
Sheth J, Bhavsar R, Mistri M, Pancholi D, Bavdekar A, Dalal A, et al. Gaucher disease: single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation. BMC Med Genet. 2019;20:31.
Mishra R, Bijarnia-Mahay S, Sharma N, Dimri N, Saxena R, Puri RD, et al. Gaucher disease in fetus: the usual and the unusual presentations in a family. J Fetal Med. 2019;6:147–50.
Koprivica V, Stone DL, Park JK, Callahan M, Frisch A, Cohen IJ, et al. Analysis and classification of 304 mutant alleles with type 1 and type3 in Gaucher patients disease. Am J Hum Genet. 2000;66:1777–86.
Huie ML, Tsujino S, Sklower Brooks S, Engel A, Elias E, Bonthron DT, et al. Glycogen storage disease type II: identification of four novel missense mutations (D645N, G648S, R672W, R672Q) and two insertions/deletions in the acid alpha-glucosidase locus of patients of differing phenotype. Biochem Biophys Res Commun. 1998;244:921–7.
Ngiwsara L, Wattanasirichaigoon D, Tim-Aroon T, Rojnueangnit K, Noojaroen S, Khongkraparn A, et al. Clinical course, mutations and its functional characteristics of infantile-onset Pompe disease in Thailand. BMC Med Genet. 2019;20:156.
Gupta N, Kazi ZB, Nampoothiri S, Jagdeesh S, Kabra M, Puri RD, et al. Clinical and molecular disease Spectrum and outcomes in patients with infantile-onset Pompe disease. J Pediatr. 2020;216:44–50.e5.
Jaworek TJ, Kausar T, Bell SM, Tariq N, Maqsood MI, Sohail A, et al. Molecular genetic studies and delineation of the oculocutaneous albinism phenotype in the Pakistani population. Orphanet J Rare Dis. 2012;7:44.
Williams EL, Acquaviva C, Amoroso A, Chevalier F, Coulter-Mackie M, Monico CG, et al. Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene. Hum Mutat. 2009;30:910–7.
Chanchlani R, Sinha A, Gulati A, Agarwal V, Bagga A. Common mutation underlying primary hyperoxaluria type1 in three Indian children. Indian J Nephrol. 2012;22:459–61.
Bijarnia S, Kohli S, Puri RD, Jacob RJ, Saxena R, Jalan A, et al. Molecular characterisation and prenatal diagnosis of Asparto-acylase deficiency (Canavan disease)-report of two novel and two known mutations from the Indian subcontinent. Indian J Pediatr. 2013;80:26–31.
Leal J, Ades AE, Wordsworth S, Dezateux C. Regional differences in the frequency of the c.985A>G ACADM mutation: findings from a meta-regression of genotyping and screening studies. Clin Genet. 2014;85:253–9.
Gorospe JR, Singhal BS, Kainu T, Wu F, Stephan D, Trent J, et al. Indian Agarwal megalencephalic leukodystrophy with cysts is caused by a common MLC1 mutation. Neurology. 2004;62:878–82.
Bijarnia-Mahay S, Movva S, Gupta N, Sharma D, Puri RD, Kotecha U, et al. Molecular diagnosis of hereditary fructose intolerance: founder mutation in a community from India. JIMD Rep. 2015;19:85–93.